Grundlæggende statistik
| CIK | 1364896 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to MedPro Safety Products, Inc.
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| September 25, 2019 |
MPSP / MedPro Safety Products, Inc. REVOKED - - begin 644 filename1 M)5!$1BTQ+C4-"B6UM;6U#0HQ(# @;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#8O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X M6R P(# @-C$R(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R M=6-T4&%R96YT)RM&VM3W#CR. |
|
| October 26, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2018 MEDPRO SAFETY PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000 – 52077 91-2015980 (state or other jurisdiction o |
|
| October 26, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2018 MEDPRO SAFETY PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000 – 52077 91-2015980 (state or other jurisdiction of incorporation) ( |
|
| March 6, 2018 |
EXHIBIT 99.1 1 2 3 |
|
| March 6, 2018 |
MPSP / MedPro Safety Products, Inc. / Alessi William Rosario Jr - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) CUSIP Number: 58504M 10 0 William R. Alessi, Jr. 20311 Chartwell Center Drive, Suite 1469 Cornelius, NC 28031 (704) 790-9799 (Name, Addre |
|
| March 2, 2018 |
Changes in Control of Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2018 MEDPRO SAFETY PRODUCTS, INC. |
|
| April 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 8, 2014 MEDPRO SAFETY PRODUCTS, INC. |
|
| January 8, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 18)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| December 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 12, 2013 MEDPRO SAFETY PRODUCTS, INC. |
|
| December 30, 2013 |
Exhibit 10.1 December 24, 2013 MedPro Safety Products, Inc. 817 Winchester Road, Suite 200 Lexington, KY 40505 Attn: Craig Turner Re: Amendment to Maturity Date of Series D Note and Promissory Note Dear Craig: Reference is made to that certain Series D Senior Secured Promissory Note dated September 12, 2012 (the "Series D Note"), made by MedPro Safety Products, Inc. ("MedPro") to Vision Opportunit |
|
| December 20, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 17)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| December 17, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 11, 2013 MEDPRO SAFETY PRODUCTS, INC. |
|
| November 13, 2013 |
MPSP-10Q 09.30.2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) T QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Quarter Ended September 30, 2013 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 11, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 16)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| October 10, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 15)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| August 15, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 14)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| August 9, 2013 |
MedPro Safety Products 10-Q (Quarterly Report) MPSP-10Q 06.30.2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) T QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Quarter Ended June 30, 2013 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| July 8, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 13)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| June 25, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 12)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| June 11, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 11)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| May 21, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 10)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 5 |
|
| May 15, 2013 |
MedPro Safety Products 10-Q (Quarterly Report) MPSP-3.31.13-10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) T QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Quarter Ended March 31, 2013 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000 |
|
| April 19, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 9)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| April 3, 2013 |
MPSP / MedPro Safety Products, Inc. / Merkatz Andrew - AMENDMENT NO. 8 Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 8)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| March 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 18, 2013 MEDPRO SAFETY PRODUCTS, INC. |
|
| March 5, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 7)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| February 5, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 6)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| January 7, 2013 |
Exhibit 10.1 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (the “Agreement”), dated as of December 31, 2012 (the “Effective Date”), is made by and between (i) MEDPRO SAFETY PRODUCTS INC., a Nevada Corporation (“MedPro Safety”), and MEDPRO INVESTMENTS LLC, a Delaware limited liability company (“MedPro Investments”) (collectively, “Seller”); and (ii) GREINER BIO-ONE GmbH, an Austrian compan |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 31, 2012 MEDPRO SAFETY PRODUCTS, INC. |
|
| January 7, 2013 |
EX-3.1 2 v331535ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 CERTIFICATE OF DESIGNATION OF THE RELATIVE RIGHTS AND PREFERENCES OF THE SERIES E CONVERTIBLE PREFERRED STOCK OF MEDPRO SAFETY PRODUCTS, INC. The undersigned, the Chief Executive Officer of MedPro Safety Products, Inc., a Nevada corporation (the “Company”), in accordance with the provisions of the Nevada Revised Statutes, does hereby certify that, |
|
| January 3, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 5)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| December 5, 2012 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 4)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| November 8, 2012 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 3)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| October 5, 2012 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 2)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| September 26, 2012 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1)* MEDPRO SAFETY PRODUCTS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 58504M100 (CUSIP Number) Vision Capital Advisors, LLC 20 West 55 |
|
| September 18, 2012 |
8-K 1 v3240168k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 12, 2012 MEDPRO SAFETY PRODUCTS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-52077 91-2015980 (State or other jurisdict |
|
| September 18, 2012 |
Certificate of Designation (PURSUANT TO NRS 78.1955) EX-3.1 2 v324016ex3-1.htm EXHIBIT 3.1 EXHIBIT 3.1 ROSS MILLER Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89701-4299 (775) 684-5708 Website: secretaryofstate.biz Filed in the office of Ross Miller Secretary of State State of Nevada Document Number 20120627719-37 Certificate of Designation (PURSUANT TO NRS 78.1955) Filing Date and Time 09/12/2012 2:00 PM Entity Number C319 |
|
| September 18, 2012 |
SERIES D SENIOR SECURED PROMISSORY NOTE EXHIBIT 10.1 US $4,235,000 September 12, 2012 New York, New York SERIES D SENIOR SECURED PROMISSORY NOTE For value received, and on the terms and subject to the conditions set forth herein, MedPro Safety Products, Inc., a corporation formed and existing under the laws of the State of Nevada (the “Company”), HEREBY PROMISES TO PAY to Vision Opportunity Master Fund, Ltd. (the “Noteholder”), on the M |
|
| August 30, 2012 |
Submission of Matters to a Vote of Security Holders - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 28, 2012 MEDPRO SAFETY PRODUCTS, INC. |
|
| August 1, 2012 |
- DEFINITIVE ADDITIONAL MATERIALS SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 MedPro Safety Products, Inc. |
|
| July 31, 2012 |
SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 MedPro Safety Products, Inc. |
|
| February 29, 2012 |
Exhibit 99 MedPro Safety Products, Inc. Releases 2011 Financial Results Reports on Progress and Recent Corporate Developments Lexington, KY – February 27, 2012 – MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on its 2011 financial results, operational progress and recent cor |
|
| February 29, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 27, 2012 MEDPRO SAFETY PRODUCTS, INC. |
|
| January 31, 2012 |
v300922ex99-1 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing |
|
| January 31, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 31, 2012 MEDPRO SAFETY PRODUCTS, INC. |
|
| January 31, 2012 |
January 31, 2012 Via E-mail Mr. Mark T. Ray Chief Financial Officer MedPro Safety Products, Inc. 145 Rose Street Lexington, KY 40507 RE: MedPro Safety Products, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 29, 2011 File No. 000-52077 Dear Mr. Ray: We have completed our review of your filings. We remind you that our comments or changes to disclosure in response to our comm |
|
| January 20, 2012 |
MedPro Safety Products, Inc. 145 Rose Street Lexington, KY 40507 859-225-5375 January 20 2011 Jeffrey Jaramillo Accounting Branch Chief United States Securities and Exchange Commission Washington, D.C. 20549 Attention: Dennis Hult Staff Accountant RE: MedPro Safety Products, Inc. ("MedPro") Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 29, 2011 Form 10-Q for the Fiscal Quarter |
|
| January 12, 2012 |
MedPro Safety Products, Inc. 145 Rose Street Lexington, KY 40507 859-225-5375 January 12, 2011 Jeffrey Jaramillo Accounting Branch Chief United States Securities and Exchange Commission Washington, D.C. 20549 Attention: Dennis Hult Staff Accountant RE: MedPro Safety Products, Inc. ("MedPro") Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 29, 2011 Form 10-Q for the Fiscal Quarter |
|
| December 13, 2011 |
MedPro Safety Products, Inc. 145 Rose Street Lexington, KY 40507 859-225-5375 December 13, 2011 Jeffrey Jaramillo Accounting Branch Chief United States Securities and Exchange Commission Washington, D.C. 20549 Attention: Dennis Hult Staff Accountant RE: MedPro Safety Products, Inc. ("MedPro") Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 29, 2011 Form 10-Q for the Fiscal Quarte |
|
| December 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE November 30, 2011 Via E-mail Mr. Mark T. Ray Chief Financial Officer MedPro Safety Products, Inc. 145 Rose Street Lexington, KY 40507 RE: MedPro Safety Products, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 29, 2011 Form 10-Q for the Fiscal Quarter Ended September 30, 2 |
